TOPARP-B: A Randomised Phase 2 Trial Evaluating Two Doses of Olaparib Against Metastatic Castration-Resistant Prostate Cancer With DNA Repair Gene Aberrations
ICR Author
Author
Hall, E
De Bono, J
Porta, N
Miranda, S
Flohr, P
Ferreira, A
Riisnaes, R
Chatfield, P
Carreira, S
Yuan, W
Tunariu, N
Espinasse, A
Crespo, M
Nava Rodrigues, D
Gurel, B
Clarke, M
Curcean, A
Pereira, AR
Fowler, G
Rescigno, P
Ebbs, B
Bertan, C
Seed, G
Figueiredo, I
Type
Journal Article
Metadata
Show full item recordCollections
Research team
Cancer Biomarkers
Clinical Trials & Statistics Unit
ICR-CTSU Urology and Head and Neck Trials Team
Prostate Cancer Targeted Therapy Group
Language
eng
Date accepted
2019-10-04
License start date
2019-10-04
Citation
The Lancet Oncology
Publisher
Elsevier